Literature DB >> 28509969

Epidemiology of prostate cancer.

Matthew R Cooperberg1,2, June M Chan3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28509969     DOI： 10.1007/s00345-017-2038-0

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  1 in total

1.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702
  1 in total
  13 in total

Review 1.  Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.

Authors:  Samuel Dubinsky; Alia Thawer; Anne G McLeod; Thomas R J McFarlane; Urban Emmenegger
Journal:  Support Care Cancer       Date:  2019-05-10       Impact factor: 3.603

Review 2.  The prostate cancer focal therapy.

Authors:  Filippo Pesapane; Francesca Patella; Enrico Maria Fumarola; Edoardo Zanchetta; Chiara Floridi; Gianpaolo Carrafiello; Chloë Standaert
Journal:  Gland Surg       Date:  2018-04

3.  Tissue-based biomarkers in prostate cancer.

Authors:  Timothy N Clinton; Aditya Bagrodia; Yair Lotan; Vitaly Margulis; Ganesh V Raj; Solomon L Woldu
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-09-05

Review 4.  Natural history of castration-resistant prostate cancer in sub-Saharan African black men: a single-centre study of Nigerian men.

Authors:  Jibril O Bello
Journal:  Ecancermedicalscience       Date:  2018-01-16

5.  Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy.

Authors:  C Hoey; M Ahmed; A Fotouhi Ghiam; D Vesprini; X Huang; K Commisso; A Commisso; J Ray; E Fokas; D A Loblaw; H H He; S K Liu
Journal:  J Transl Med       Date:  2019-05-23       Impact factor: 5.531

6.  Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.

Authors:  Minyong Kang; Eunhae Cho; Jahyun Jang; Junnam Lee; Youngjoo Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Han Yong Choi; Hwang Gyun Jeon
Journal:  Investig Clin Urol       Date:  2019-06-20

7.  Incidence of prostate cancer in Eritrea: Data from the National Health Laboratory, Orotta Referral Hospital and Sembel Hospital 2011-2018.

Authors:  Lidia Biniam Medhin; Oliver Okoth Achila; Biniam Efrem Syum; Kibrom Hailu Gebremichael; Salih Mohammed Said; Hartmut Lobeck; Yosief Tewolde Ghidei
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

8.  Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP‑9 signaling pathway in DU145 cells.

Authors:  Yuan Zeng; Ying Yang
Journal:  Mol Med Rep       Date:  2018-02-28       Impact factor: 2.952

9.  Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer.

Authors:  David Pasquier; Abderraouf Hadj Henni; Alexandre Escande; Emmanuelle Tresch; Nick Reynaert; Olivier Colot; Eric Lartigau; Nacim Betrouni
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

10.  Prognostic Factors for Hormone Sensitive Metastatic Prostate Cancer: Impact of Disease Volume

Authors:  Alshimaa Mahmoud Alhanafy; Fouad Zanaty; Reda Ibrahem; Suzan Omar
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.